Clinical Trials on Secondary Prevention in China

Total 149 results

China National Center for Cardiovascular Diseases

Completed

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1)

Coronary Artery Bypass Grafting | Secondary Preventions

China
The Second Hospital of Nanjing Medical University

Recruiting

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism;Parathyroidectomy

China
Sinocelltech Ltd.

Recruiting

A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Randomized | Prevention | Interventional

China
Shanghai Cell Therapy Group Co.,Ltd

Not yet recruiting

The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)

Postoperative Prevention of Tumor

China
China National Center for Cardiovascular Diseases

Active, not recruiting

Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk (SMARTER)

Cardiovascular Diseases | Primary Prevention | Risk Reduction

China
China-Japan Friendship Hospital

Recruiting

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Wenhu Liu

Unknown

The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Secondary Hyperparathyroidism | Maintenance Hemodialysis

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Prevention of Graft Rejection After Organ Transplantation

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Beijing Friendship Hospital

Unknown

the Study on Prognostic for Hemodialysis Patients

Secondary Hyperparathyroidism

China
Boehringer Ingelheim

Completed

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Stroke | Secondary Prevention

Korea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
Fifth Affiliated Hospital, Sun Yat-Sen University

Completed

Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

Secondary Hyperparathyroidism | Parathyroid Gland Disease

China
Sichuan Provincial People's Hospital

Recruiting

Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis (PATH-ICAS)

Ischemic Stroke | Intracranial Arteriosclerosis | Secondary Prevention | Antiplatelet Drug

China
Zhang longjiang,MD

Recruiting

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population (RESPECT2)

Adherence, Medication | Primary Prevention | Cardiovascular Risk Factors | Statin

China
Kyowa Kirin China Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)

Hyperparathyroidism; Secondary, Renal

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Trial of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Shanghai Changning Maternity & Infant Health Hospital
Tongji University

Unknown

Comparison of 2 Body Oil in Prevention of Striae Gravidarum

Prevention Harmful Effects

China
Xiaohui Su

Completed

Secondary Ear Reconstructions Based on Nagata Method

Secondary Ear Reconstructions Based on Nagata Method

China
Tianjin Medical University Cancer Institute and...

Recruiting

Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism

Secondary Hypersplenism

China
Jilin University

Recruiting

Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development

Breast Cancer Prevention

China
The Second Hospital of Anhui Medical University

Unknown

Comparison of Total Parathyroidectomy With and Without Autotransplantation

Secondary Hyperparathyroidism

China
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

SARS-CoV-2 | Prevention

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

Prevention of COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Prevention of COVID-19

China
First Affiliated Hospital of Chengdu Medical College

Recruiting

Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

Primary Aldosteronism | Resistant Hypertension | Secondary Hypertension | Secondary Hypertension to Endocrine Disorders

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

China
Peking University

Completed

A Dose-response Study to Validate the Biomarkers for Whole Grain Dietary Intake

Chronic Disease Prevention

China
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Not yet recruiting

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

High-risk (Secondary) Acute Myeloid Leukemia

China
Amgen

Completed

A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416

Secondary Hyperparathyroidism

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML

Secondary Acute Myeloid Leukemia

China
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.

Completed

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Secondary Hyperparathyroidism

China, Hong Kong, Korea, Republic of, Taiwan
Peking University First Hospital

Recruiting

Anesthesia-handover Checklist and Perioperative Outcomes in Elderly

Postoperative Complications | Elderly Patients | Prevention | Major Surgery | Anesthesia; Adverse Effect

China
Peking University

Recruiting

R-MTX-zanbrutinib in Secondary CNS Lymphoma

Secondary Central Nervous System Lymphoma

China
Guang'anmen Hospital of China Academy of Chinese...

Recruiting

Electroacupuncture for Patients With Chronic Urinary Retention Secondary to Lower Motor Neuron Lesion (CUR)

Chronic Urinary Retention

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy

Urinary Retention After Procedure

China
Fujian Shengdi Pharmaceutical Co., Ltd.

Completed

Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy

China
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation

Vitamin D Deficiency | Chronic Kidney Disease 5D | Secondary Hyperparathyroidism Due to Renal Causes

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Recruiting

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning | Secondary Acute Myeloid Leukemia Evolving From MDS

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty

Prevention of Venous Thrombosis After TKA

China
Sanofi

Completed

Alfuzosin for Treating Acute Urinary Retention

Acute Urinary Retention

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Active, not recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects

Prevention of Arterial and Venous Thrombosis

China
Fujian Shengdi Pharmaceutical Co., Ltd.

Completed

Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

PCNSL | Secondary Central Nervous System Lymphoma

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Recruiting

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty

China
University of Southern Queensland
The Hong Kong Polytechnic University

Completed

Virtual Reality Activity-based Training for Preventing Falls for Older Adults With Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment | Exercise Training | Virtual Reality | Fall Prevention

Hong Kong
Chengdu Kanghong Biotech Co., Ltd.

Unknown

An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) (LAMP)

Very Low Vision Secondary to Wet Age-related Macular Degeneration

China
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Recruiting

A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Primary Central Nervous System Lymphoma | Secondary Central Nervous System Lymphoma

China
The First Affiliated Hospital of Dalian Medical...

Recruiting

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Long-Term Effects Secondary to Cancer Therapy

China
The Hong Kong Polytechnic University

Completed

The Effectiveness of a Pressure Ulcer Prevention Programme for Older People in For-profit Private Nursing Homes

Prevention of Pressure Ulcers

China
West China Hospital
Beijing Tiantan Hospital; First Affiliated Hospital of Chongqing Medical University and other collaborators

Completed

Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP)

Stroke | Cardiovascular Disease | Primary Prevention

China

Clinical Trials on Secondary Prevention in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations